跳至主要内容
临床试验/NCT01582607
NCT01582607Unknown2 期

Intrathecal Plain Bupivacaine, Ropivacaine and Levo-bupivacaine With or Without Fentanyl for Elective c Section.

University of Patras1 个研究点 分布在 1 个国家目标入组 130 人开始时间: 2010年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
入组人数
130
试验地点
1
主要终点
Sensory block

研究概览

简要总结

The purpose of the investigators study is to compare the clinical effects and side-effects of these three local anaesthetics as sole agents or with the supplementation with fentanyl for c-section, especially when administered in doses achieving approximately an ED 50.

详细描述

Intrathecal (i.t.) administration of isobaric bupivacaine, ropivacaine and levobupivacaine with or without addition of fentanyl for c-section do not exist to date .

Parturients scheduled for elective caesarean section will be allocated to receive double-blindly i.t. isobaric bupivacaine 10 mg, ropivacaine 15mg , levobupivacaine 10mg or the same local anaesthetics with 10 μg fentanyl respectively. Sensory block (pin prick test) and motor block (Bromage scale) profile, intraoperative and postoperative analgesia, haemodynamics and side effects will be assessed.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Double (Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 40 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Parturients scheduled for elective c section
  • Stillborn
  • Normal cardiotocogram

排除标准

  • BMI>35kg/m2
  • Height <150cm or >185cm
  • Age (<18, >40)
  • ASA > II
  • Multiple gestation
  • Pregnancy complications (eclampsia, GDP, placenta previa, >2 previous c section)
  • Contraindication to spinal anaesthesia
  • Failure to educate the patient, language barrier
  • Patient preferred GA

研究组 & 干预措施

Group B

Active Comparator

subarachnoid administration of 2.0 mL (10mg) plain bupivacaine hydrochloride 0.5%

干预措施: Bupivacaine plain (Drug)

Group R

Active Comparator

subarachnoid administration of 2.0 ml (15mg) plain ropivacaine 0.75%

干预措施: Ropivacaine plain (Drug)

Group LB

Active Comparator

subarachnoid administration of 2.0 ml (10mg) plain levo-bupivacaine hydrochloride 0.5%

干预措施: Levobupivacaine plain (Drug)

Group RF

Active Comparator

subarachnoid administration of 2.0 ml (15mg) plain ropivacaine 0.75% with 0.2 ml (10 μg) fentanyl

干预措施: ropivacaine plain +. fentanyl (Drug)

Group BF

Active Comparator

subarachnoid administration of 2.0 ml (10mg) plain bupivacaine 0.5% with 0.2 ml (10 μg) fentanyl

干预措施: bupivacaine plain +fentanyl (Drug)

Group LBF

Active Comparator

subarachnoid administration of 2.0 ml (10mg) plain levo-bupivacaine 0.5% with 0.2 ml (10 μg) fentanyl

干预措施: Levobupivacaine plain +fentanyl (Drug)

结局指标

主要结局

Sensory block

时间窗: up to 150 minutes average

sensory block (pin prick test): every 1 min until 30min, every 5 min until 60min. every 10 min until regression to O1 (average 150 minutes)

Motor block

时间窗: up to 150 minutes

Motor block (Bromage scale): every 1 min until 30min, every 5 min until 60min. every 10 min until complete recovery of motor function (average 150 minutes)

次要结局

  • Hemodynamics profile (arterial pressure. heart rate)(up to 150 minutes average)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Nikolaos G. Flaris

Anesthesiologist,MD

University of Patras

研究点 (1)

Loading locations...

相似试验